
Keloid Treatment Market Trends
Keloid Treatment Market Research Report Information By Product (Elastic Wraps, Ointment), by Treatment (Radiation Therapy, Cry Therapy, Surgical Treatment, Laser Treatment, Laser Treatment, Interferon), by End-User (Hospitals and Others), Regions - Forecast till 2035

Market Summary
The Global Keloid Treatment Market is projected to grow from 1.73 USD Billion in 2024 to 1.9 USD Billion by 2035.
Key Market Trends & Highlights
Keloid Treatment Key Trends and Highlights
- The market is expected to experience a compound annual growth rate (CAGR) of 0.86% from 2025 to 2035.
- By the year 2035, the market valuation is anticipated to reach 1.9 USD Billion, reflecting steady growth.
- In 2024, the market is valued at 1.73 USD Billion, indicating a solid foundation for future expansion.
- Growing adoption of advanced treatment modalities due to increasing awareness of keloid management is a major market driver.
Market Size & Forecast
2024 Market Size | 1.73 (USD Billion) |
2035 Market Size | 1.9 (USD Billion) |
CAGR (2025-2035) | 0.86% |
Largest Regional Market Share in 2024 | latin_america) |
Major Players
Novartis, AGRXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation, Avita Medical Limited, Sensus Healthcare, Perrigo Company plc
Market Trends
The increasing prevalence of keloids, coupled with advancements in treatment modalities, suggests a burgeoning demand for effective therapeutic solutions in the global market.
U.S. National Library of Medicine
Keloid Treatment Market Market Drivers
Market Growth Projections
The Global Keloid Treatment Market Industry is projected to experience steady growth, with estimates indicating a market size of 1.73 USD Billion in 2024 and a potential increase to 1.9 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 0.86% from 2025 to 2035. Such projections highlight the ongoing demand for keloid treatments and the industry's responsiveness to emerging trends and technologies. The market's expansion reflects broader healthcare trends, including a focus on personalized medicine and improved patient care.
Rising Cosmetic Procedures
The rise in cosmetic procedures is another driver for the Global Keloid Treatment Market Industry. As more individuals undergo surgeries for aesthetic enhancements, the likelihood of keloid formation increases. This trend is particularly pronounced in regions where cosmetic surgery is gaining popularity. Patients seeking to minimize the appearance of keloids post-surgery are driving demand for effective treatment solutions. The market's growth is expected to be sustained as the beauty industry continues to expand, with keloid treatments becoming an integral part of post-operative care.
Rising Prevalence of Keloids
The Global Keloid Treatment Market Industry is experiencing growth due to the rising prevalence of keloids, which are often associated with surgical scars, acne, and trauma. As awareness increases regarding the condition, more individuals seek treatment options. In 2024, the market is projected to reach 1.73 USD Billion, reflecting a growing demand for effective therapies. This trend is particularly evident in regions with high rates of skin injuries, such as urban areas where surgical procedures are common. The increasing incidence of keloids is likely to drive innovation in treatment modalities, further expanding the market.
Growing Awareness and Education
The Global Keloid Treatment Market Industry benefits from increasing awareness and education about keloids among both healthcare professionals and patients. Educational campaigns and resources provided by dermatological associations are helping to demystify keloids, leading to earlier diagnosis and treatment. This heightened awareness is crucial, as it encourages individuals to seek medical advice sooner, thereby increasing treatment uptake. As more patients become informed about their options, the market is likely to see a steady rise in demand for keloid treatments, contributing to a projected CAGR of 0.86% from 2025 to 2035.
Increased Research and Development
Increased investment in research and development is propelling the Global Keloid Treatment Market Industry forward. Pharmaceutical companies and research institutions are focusing on understanding the underlying mechanisms of keloid formation, which may lead to the discovery of novel therapeutic agents. This emphasis on R&D is likely to yield new treatment options that are more effective and tailored to individual patient needs. As the market evolves, the introduction of innovative therapies could significantly alter the treatment landscape, enhancing patient satisfaction and outcomes.
Advancements in Treatment Technologies
Innovations in treatment technologies are significantly influencing the Global Keloid Treatment Market Industry. New methods, such as laser therapy, cryotherapy, and intralesional injections, are being developed and refined, offering patients more effective options. These advancements not only enhance treatment efficacy but also reduce recovery times and side effects. As a result, healthcare providers are increasingly adopting these technologies, contributing to market growth. The anticipated increase in market size to 1.9 USD Billion by 2035 underscores the potential of these advancements to reshape treatment paradigms and improve patient outcomes.
Market Segment Insights
Keloid Treatment Product Type Insights
Based on product type the market is segmented into elastic wraps, spray, ointment, creams, oils, topical gels & gel sheets.
Keloid Treatment Insights
Based on treatment market for keloid has been segmented into ligature, radiation therapy, cry therapy, surgical treatment, laser treatment, steroid injections, corticosteroid injections (intralesional steroids), silicone gel or sheeting, occlusive dressing, compression therapy, and interferon. Corticosteroid injections treatment segments lead the keloid treatment market as this treatment is used in combination with other therapies. Intralesional steroids injection is considered to be the second largest segment of treatment type that drives market.
Keloid Treatment End-User Insights
On the basis of end-users, the keloid treatment market is segmented into dermatology clinics, hospitals, ambulatory surgical centers. Hospital is expected to hold the largest share in the segment market of end-users as most doctors prefer radiation therapy which has reported safe and effective use of radiation to treat keloid.
Get more detailed insights about Keloid Treatment Market Research Report - Global Forecast till 2032
Regional Insights
Key Companies in the Keloid Treatment Market market include




Industry Developments
POETYK PSO-2, the second pivotal Phase III clinical trial assessing deucravacitinib, a new, selective tyrosine kinase 2 inhibitor for the treatment of patients with moderate to severe plaque psoriasis, was published in February 2021 by Bristol Myers Squibb Company.
POETYK PSO-2 looked at deucravacitinib 6 mg once a day and found that it met both co-primary objectives, with considerably more patients reaching Psoriasis Area and Severity Index (PASI 75). JUBLIA (efinaconazole) topical solution for the treatment of onychomycosis was approved by the US Food and Drug Administration (FDA) in April 2020 for Bausch Health Companies Inc. and its dermatology business Ortho Dermatologics in Keloid Treatment Market
Intended Audience
- Manufacturers and Suppliers
- Dermatology Hospitals and Clinics
- Dermatology laboratories and associations
- Research and development centers
Future Outlook
Keloid Treatment Market Future Outlook
The Global Keloid Treatment Market is projected to grow at a 0.86% CAGR from 2024 to 2035, driven by advancements in treatment technologies and increasing awareness of skin conditions.
New opportunities lie in:
- Develop targeted therapies utilizing gene editing techniques for keloid prevention.
- Expand telemedicine platforms for remote consultations and follow-ups in keloid treatment.
- Invest in educational campaigns to raise awareness about keloid management options.
By 2035, the Keloid Treatment Market is expected to stabilize, reflecting gradual growth and evolving treatment paradigms.
Market Segmentation
Keloid Treatment Region Outlook
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- Republic of Korea
- Rest of Asia Pacific
- Middle East & Africa
- Middle East
- Africa
- Manufacturers and Suppliers
- Dermatology Hospitals and Clinics
- Dermatology laboratories and associations
- Research and development centers
Keloid Treatment End User Outlook
- Dermatology clinics
- Hospitals
- Ambulatory surgical centers
- Others
Keloid Treatment Treatment Outlook
- Ligature
- Radiation Therapy
- Cry Therapy
- Surgical Treatment
- Laser Treatment
- Steroid Injections
- Corticosteroid injections (intralesional steroids)
- Silicone gel or sheeting
- Interferon
Keloid Treatment Product Type Outlook
- Elastic Wraps
- Sprays
- Ointment
- Creams
- Oils
- Topical Gels & Gel Sheets
Report Scope
Report Attribute/Metric | Details |
Market Size | USD 1.72 Billion |
CAGR | 3.3% |
Base Year | 2021 |
Forecast Period | 2023-2032 |
Historical Data | 2020 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | By Product, Treatment, End-User |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Novartis AG, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation, Avita Medical Limited, Sensus Healthcare, Perrigo Company plc. |
Key Market Opportunities | Increasing research & development investments by industry players |
Key Market Drivers | · Rapid rise in the technological scenario behind skin care products · Treatment type - Intralesional steroids injection |
Market Highlights
Author
Latest Comments
This is a great article! Really helped me understand the topic better.
Thanks for sharing this. I’ve bookmarked it for later reference.
FAQs
What is the valuation of the global keloid market?
The global keloid market is expected to reach a valuation of USD 1.72 billion by 2032.
What is the CAGR of the market?
The market is expected to exhibit a strong 3.3% CAGR over the forecast period from 2023-2032.
What is the leading driver for the market?
The rapid rise in the technological scenario behind skin care products is the major driver for the global keloid treatment market.
What is the leading regional market?
North America is the dominant regional market for keloid treatment.
What are the key players in the market?
Leading players in the keloid treatment market include Valeant, RXi Pharmaceuticals, Novartis, and Pacific World Corporation, among others.
-
Table of Contents:
-
Chapter 1. Report Prologue
-
Chapter 2. Market Introduction
-
- Definition
-
Scope of the Study
- Research Objective
- Assumptions
- Limitations
-
Chapter 3. Research Methodology
- Introduction
- Primary Research
- Secondary Research
- Market Size Estimation
-
Chapter 4. Market Dynamics
- Drivers
- Restraints
- Opportunities
- Challenges
- Macroeconomic Indicators
- Technology Trends & Assessment
-
Chapter 5. Market Factor Analysis
-
Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Value Chain Analysis
- Investment Feasibility Analysis
- Pricing Analysis
-
Porter’s Five Forces Analysis
-
Chapter 6. Global Keloid Treatment Market, by Product
- Introduction
- Elastic Wraps
-
Market Estimates & Forecast, by Region, 2020–2027
-
Market Estimates & Forecast, by Country, 2020–2027
- Sprays
-
Market Estimates & Forecast, by Country, 2020–2027
- Ointment
- Creams
- Oils
-
Market Estimates & Forecast, by Region, 2020–2027
-
Market Estimates & Forecast, by Country, 2020–2027
- Topical Gels & Gel Sheets
-
Market Estimates & Forecast, by Country, 2020–2027
-
Chapter 7. Global Keloid Treatment Market, by Treatment
- Introduction
- Ligature
- Radiation Therapy
- Cryo Therapy
- Surgical Treatment
- Laser Treatment
- Steroid Injections
- Corticosteroid injections (intralesional steroids)
-
Market Estimates & Forecast, by Region, 2020–2027
- Silicone gel or sheeting
-
Market Estimates & Forecast, by Region, 2020–2027
- Interferon
-
Chapter 8. Global Keloid Treatment Market, by End User
- Introduction
- Dermatology Clinics
- Hospitals
- Ambulatory Surgical Centers
-
Market Estimates & Forecast, by Region, 2020–2027
-
Market Estimates & Forecast, by Country, 2020–2027
-
Chapter 9. Global Keloid Treatment Market, by Region
- Introduction
-
Americas
- North America
- South America
-
Europe
- Western Europe
- Eastern Europe
-
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
-
Middle East & Africa
- Middle East
- Africa
-
Chapter 10. Company Landscape
-
- Introduction
- Market Share Analysis
- Key Development & Strategies
-
Chapter 11. Company Profiles
-
Novartis AG
- Company Overview
- Product Overview
- Financials Overview
- Key Developments
- SWOT Analysis
-
RXi Pharmaceuticals, Inc
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
-
Sonoma Pharmaceuticals, Inc
- Company Overview
- Product Overview
- Financial Overview
- Key Development
- SWOT Analysis
-
Bristol-Myers Squibb
- Company Overview
- Product Overview
- Financial Overview
- Key Development
- SWOT Analysis
-
Pacific World Corporation
- Company Overview
- Product Overview
- Financial overview
- Key Developments
- SWOT Analysis
-
Valeant Pharmaceuticals International, Inc
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
-
Revitol Corporation
- Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
-
Avita Medical Limited
- Overview
- Product Overview
- Financials
- Key Developments
- SWOT Analysis
-
Sensus Healthcare
- Overview
- Product Overview
- Financials
- Key Developments
- SWOT Analysis
-
Perrigo Company plc
- Overview
- Product Overview
- Financials
- Key Developments
- SWOT Analysis
-
Novartis AG
-
Chapter 12 MRFR Conclusion
-
Key Findings
- From CEO’s Viewpoint
- Unmet Needs of the Market
- Key Companies to Watch
- Predictions for the Keloid Treatment Industry
-
Key Findings
-
Chapter 13. Appendix
-
-
List of Tables and Figures
- LIST OF TABLES
- Table 1 Global Keloid Treatment Market Synopsis, 2020–2027
- Table 2 Global Keloid Treatment Market Estimates and Forecast, 2020–2027 (USD Million)
- Table 3 Global Keloid Treatment Market, by Region, 2020–2027 (USD Million)
- Table 4 Global Keloid Treatment Market, by Product, 2020–2027 (USD Million)
- Table 5 Global Keloid Treatment Market, by Treatment, 2020–2027(USD Million)
- Table 6 Global Keloid Treatment Market, by End User, 2020–2027 (USD Million)
- Table 7 North America: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
- Table 8 North America: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
- Table 9 North America: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
- Table 10 US: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
- Table 11 US: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
- Table 12 US: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
- Table 13 Canada: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
- Table 14 Canada: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
- Table 15 Canada: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
- Table 16 South America: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
- Table 17 South America: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
- Table 18 South America: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
- Table 19 Europe: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
- Table 20 Europe: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
- Table 21 Europe: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
- Table 22 Western Europe: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
- Table 23 Western Europe: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
- Table 24 Western Europe: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
- Table 25 Eastern Europe: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
- Table 26 Eastern Europe: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
- Table 27 Eastern Europe: Keloid Treatment Market, by End User, 2020–2027(USD Million)
- Table 28 Asia-Pacific: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
- Table 29 Asia-Pacific: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
- Table 30 Asia-Pacific: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
- Table 31 Middle East & Africa: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
- Table 32 Middle East & Africa: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
- Table 33 Middle East & Africa: Keloid Treatment Market, by End User, 2020–2027 (USD Million) LIST OF FIGURES
- Figure 1 Research Process
- Figure 2 Segmentation for Global Keloid Treatment Market
- Figure 3 Segmentation Market Dynamics for Global Keloid Treatment Market
- Figure 4 Global Keloid Treatment Market Share, by Product, 2020
- Figure 5 Global Keloid Treatment Market Share, by Treatment, 2020
- Figure 6 Global Keloid Treatment Market Share, by End User, 2020
- Figure 7 Global Keloid Treatment Market Share, by Region, 2020
- Figure 8 North America: Keloid Treatment Market Share, by Country, 2020
- Figure 9 Europe: Keloid Treatment Market Share, by Country, 2020
- Figure 10 Asia-Pacific: Keloid Treatment Market Share, by Country, 2020
- Figure 11 Middle East & Africa: Keloid Treatment Market Share, by Country, 2020
- Figure 12 Global Keloid Treatment Market: Company Share Analysis, 2020 (%)
- Figure 13 Novartis AG: Key Financials
- Figure 14 Novartis AG: Segmental Revenue
- Figure 15 Novartis AG: Geographical Revenue
- Figure 16 RXi Pharmaceuticals, Inc: Key Financials
- Figure 17 RXi Pharmaceuticals, Inc: Segmental Revenue
- Figure 18 RXi Pharmaceuticals, Inc: Geographical Revenue
- Figure 19 Sonoma Pharmaceuticals, Inc: Key Financials
- Figure 20 Sonoma Pharmaceuticals, Inc: Segmental Revenue
- Figure 21 Sonoma Pharmaceuticals, Inc: Geographical Revenue
- Figure 22 Bristol-Myers Squibb : Key Financials
- Figure 23 Bristol-Myers Squibb : Segmental Revenue
- Figure 24 Bristol-Myers Squibb : Geographical Revenue
- Figure 25 Pacific World Corporation: Key Financials
- Figure 26 Pacific World Corporation: Segmental Revenue
- Figure 27 Pacific World Corporation. Geographical Revenue
- Figure 28 Valeant Pharmaceuticals International, Inc: Key Financials
- Figure 29 Valeant Pharmaceuticals International, Inc: Segmental Revenue
- Figure 30 Valeant Pharmaceuticals International, Inc: Geographical Revenue
- Figure 31 Revitol Corporation: Key Financials
- Figure 32 Revitol Corporation: Segmental Revenue
- Figure 33 Revitol Corporation: Geographical Revenue
- Figure 34 Avita Medical Limited: Key Financials
- Figure 35 Avita Medical Limited: Segmental Revenue
- Figure 36 Avita Medical Limited: Geographical Revenue
- Figure 37 Sensus Healthcare: Key Financials
- Figure 38 Sensus Healthcare: Segmental Revenue
- Figure 39 Sensus Healthcare: Geographical Revenue
- Figure 40 Perrigo Company plc: Key Financials
- Figure 41 Perrigo Company plc: Segmental Revenue
- Figure 42 Perrigo Company plc: Geographical Revenue
Keloid Treatment Market Segmentation
Market Segmentation Overview
- Detailed segmentation data will be available in the full report
- Comprehensive analysis by multiple parameters
- Regional and country-level breakdowns
- Market size forecasts by segment

Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment